Quantitative Bioanalysis of Oligonucleotides Using a 6495D Triple Quadrupole LC/MS System Combined with an Automated SPE Workstation

Importance of the Topic

Quantitative analysis of oligonucleotide therapeutics in complex biological matrices is essential for pharmacokinetic, pharmacodynamic and safety assessments. The structural diversity and matrix interferences associated with these molecules demand highly sensitive, selective and reproducible methods.

Goals and Overview of the Study

This application note demonstrates an integrated workflow combining an automated solid phase extraction workstation with an Agilent 6495D triple quadrupole LC/MS system. The performance is exemplified by quantifying the antisense oligonucleotide mipomersen in pig plasma, highlighting improvements in throughput and data quality.

Methodology and Instrumentation

The workflow automates key sample preparation steps on the Agilent Bravo platform with BenchCel and MiniHub modules for:

• Blank and internal standard addition
• Lysis and loading buffer mixing
• SPE conditioning, equilibration and two-stage washing
• Elution, nitrogen drying and sample reconstitution

Chromatographic separation was achieved on an AdvanceBio Oligonucleotide column (2.1×50 mm, 2.7 µm) using a gradient of aqueous and methanolic mobile phases containing 0.4% triethylamine and 2% hexafluoroisopropanol. Detection was performed on the 6495D triple quadrupole LC/MS system with iFunnel technology in negative electrospray mode, delivering high sensitivity and low limits of detection.

Main Results and Discussion

The method demonstrated a linear dynamic range of 2–1 000 ng/mL with R²>0.999. Intra-batch precision (RSD) was below 5% for most QC levels, and accuracy ranged from 85 to 115%. Over a three-day repeatability study, inter-batch RSD remained under 10% and LLOQ recoveries stayed between 80 and 120%. The fully automated SPE process required approximately two hours per 96-well plate, reducing manual intervention time by more than 80%.

Benefits and Practical Applications

By minimizing manual steps and enhancing traceability, the automated SPE workstation improves consistency and throughput for high-volume bioanalysis. Coupled with the 6495D LC/MS system, this solution supports sensitive and reliable quantification of low-abundance oligonucleotides, essential for drug development, toxicology and pharmacokinetic studies.

Future Trends and Potential Applications

Future developments may include further integration with informatics platforms for real-time monitoring, expansion to diverse oligonucleotide modalities, coupling with high-resolution mass spectrometry and implementation in personalized medicine and large-scale screening workflows.

Conclusion

The combined automated SPE workstation and Agilent 6495D triple quadrupole LC/MS system provide a robust, high-throughput solution for quantitative oligonucleotide bioanalysis, fulfilling stringent requirements for sensitivity, accuracy and reproducibility in pharmaceutical research.

References

1. Clinical and Preclinical Pharmacokinetics and Pharmacodynamics of Mipomersen (Kynamro).
2. Nuckowski L, Kaczmarkiewicz A, Studzinska S. Review on Sample Preparation Methods for Oligonucleotides Analysis by Liquid Chromatography. J Chromatogr B Analyt Technol Biomed Life Sci. 2018;1090:90–100.
3. Ewles M, Goodwin L, Schneider A, Rothhammer-Hampl T. Quantification of oligonucleotides by LC-MS/MS: The challenges of quantifying a phosphorothioate oligonucleotide and multiple metabolites. Bioanalysis. 2014;6:447–464.